Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Adult 1
- Anaplasma 1
- Anaplasmosis 1
- Animals 1
- Antimalarials 1
- Artemisinins 1
- Drug Resistance 2
- Female 1
- Gene Expression Regulation 1
- Geography 1
- Gold 1
- Humans 3
- Malaria 1
- Malaria, Falciparum 2
- Malaria, Vivax 1
- Male 1
- Mefloquine 1
- Middle Aged 1
- Miners 1
- Multidrug Resistance-Associated Proteins 1
- Plasmodium falciparum 2
- Plasmodium vivax 1
- Prevalence 1
- Protozoan Proteins 1
- Rainforest 1
- Rickettsia Infections 1
- Risk 1
- Young Adult 1
Personal Author
Place as Subject
- Brazil 1
- Cambodia 1
- French Guiana 3
- Madagascar 1
- Sudan 1
Resource Type General
Resource Type Specific
- Dispatch 1
Select all docs (Max 200)
1 -
3 of 3 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Adult (1)
- Anaplasma (1)
- Anaplasmosis (1)
- Animals (1)
- Antimalarials (1)
- Artemisinins (1)
- Drug Resistance (2)
- Female (1)
- Gene Expression Regulation (1)
- Geography (1)
- Gold (1)
- Humans (3)
- Malaria (1)
- Malaria, Falciparum (2)
- Malaria, Vivax (1)
- Male (1)
- Mefloquine (1)
- Middle Aged (1)
- Miners (1)
- Multidrug Resistance-Associated Proteins (1)
- Plasmodium falciparum (2)
- Plasmodium vivax (1)
- Prevalence (1)
- Protozoan Proteins (1)
- Rainforest (1)
- Rickettsia Infections (1)
- Risk (1)
- Young Adult (1)
- :Duron, Olivier ;Koual, Rachid8 2022 | Emerg Infect Dis. 2022; 28(8):1673-1676:We report a case of unusual human anaplasmosis in the Amazon rainforest of French Guiana. Molecular typing demonstrated that the pathogen is a novel A...
- Malaria Hyperendemicity and Risk for Artemisinin Resistance among Illegal Gold Miners, French Guiana:Pommier de Santi, Vincent ;Djossou, FélixMay 2016 | Emerg Infect Dis. 22(5):903-906.:To assess the prevalence of malaria among illegal gold miners in the French Guiana rainforest, we screened 205 miners during May-June 2014. Malaria pr...
- :Khim, Nimol ;Andrianaranjaka, VoahangyOct 2014 | Emerg Infect Dis. 20(10):1637-1644.:Numerous studies have indicated a strong association between amplification of the multidrug resistance-1 gene and in vivo and in vitro mefloquine resi...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.